Listed

Carlisle Companies Inc: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Jul 27, 2021 and accepted by EDGAR at Jul 27, 2021, 14:08 ET.

Share

Management's discussion and analysis

As filed, 46,533 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Carlisle Companies Incorporated (“Carlisle”, the “Company”, “we”, “us” or “our”) is a leading supplier of innovative building envelope products and energy-efficient solutions for customers creating sustainable buildings of the future. Through its Carlisle Construction Materials ("CCM") business and family of leading brands, Carlisle delivers innovative, labor-reducing and environmentally responsible products and solutions to customers across the planet through the Carlisle Experience. Over the life of a building, Carlisle’s products help drive lower greenhouse gas emissions, improve energy savings for building owners and operators, and increase a building’s resiliency to the elements. Driven by our strategic plan, Vision 2025, Carlisle is committed to generating superior shareholder returns and maintaining a balanced capital deployment approach, including investments in our businesses, strategic acquisitions, share repurchases and continued dividend increases. Carlisle also is a leading provider of products to the aerospace, medical technologies and general industrial markets through its Carlisle Interconnect Technologies ("CIT") and Carlisle Fluid Technologies ("CFT") business segments. Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with a narrative from the perspective of Company management. All references to "Notes" refer to our Notes to Condensed Consolidated Financial Statements in Item 1 of this Quarterly Report on Form 10-Q.

Executive Overview

Carlisle's performance continues to strengthen as we accelerate into the recovery. Given our adherence to strict safety measures across our global footprint, we are happy to report Carlisle's COVID-19 related infection rates approached zero in the second quarter. Over a year removed from the pandemic's initial impact, we are well positioned to meet Carlisle's center-led Vision 2025 objectives, supported by confidence in the fundamentals of our businesses, positive long-term trends, and a commitment to providing our customers superior service through the Carlisle Experience.

On July 19, 2021, we announced the acquisition of ASP Henry Holdings, Inc. (“Henry”), a best-in-class provider of building envelope systems that control the flow of water, vapor and energy to optimize building sustainability. Henry will augment Carlisle Construction Materials' ("CCM") growth and innovation efforts in commercial construction and increases its presence in residential construction in North America.

On May 25, 2021, we announced the sale of Carlisle Brake & Friction ("CBF") to certain direct and indirect wholly-owned subsidiaries of BRWS Parent LLC, a portfolio company of One Rock Capital Partners (“CentroMotion”), in a transaction structured to provide Carlisle the opportunity to receive $375 million, including receipt of $250 million cash at closing, subject to certain adjustments, and the right to receive an additional post-closing cash payment of up to $125 million based on CBF’s achievement of certain performance targets for calendar year 2021. We expect the transaction, which is subject to customary closing conditions, to close in the third quarter of 2021. The sale of CBF is consistent with our portfolio optimization strategy as contemplated in Vision 2025.

CCM's performance continues to confirm our conviction that Carlisle's strategic pivot to our highest-returning business is the correct path. Carlisle's positive second quarter results were driven by CCM, which continues to benefit from the strong re-roofing cycle in the United States. CCM is committed to delivering the full value of the Carlisle Experience and being the manufacturer of choice with second-to-none reliability for all of our channel partners. These efforts were clearly demonstrated in the second quarter with solid execution meeting unusually strong demand despite the significant supply constraints. CCM continues to operate with agility and precision, adjusting quickly to the downturn in 2020, and just as quickly adjusting to the upturn in 2021.

While CCM generated most of our earnings in the second quarter of 2021, our other businesses exhibited continued progress. Carlisle Interconnect Technologies' ("CIT") results were in line with subdued expectations. Given expanding global vaccine rollout, increased domestic travel, European countries opening their borders to American and other vaccinated travelers, and improvements in CIT's order book, we continue to believe CIT is positioned for sequential improvement going forward. Taken together with the improving backlog in our medical technologies product lines, we are optimistic CIT will return to growth in the second half of 2021.

Carlisle Fluid Technologies ("CFT") delivered improved revenue and operating income performance in the quarter driven by a commitment to new product introductions, price discipline and integrating our newer platforms. With end markets strengthening, the team continues to execute on Vision 2025 initiatives and focus on enhancing our customers' experience.

We remain balanced in our capital deployment approach by investing in our businesses, repurchasing $265.6 million of shares and maintaining our cash dividend payments of $56.0 million during the first six months. As of the end of the second quarter, we have a strong cash position of $713.3 million with $1.0 billion undrawn on our revolving credit facility (the "Facility").

Vision 2025 continues to provide Carlisle clear direction. We have stayed the course on our strategy throughout the past year and a half and have regained positive momentum across all segments. We believe we are well positioned to accelerate through the recovery and beyond.

Summary of Financial Results

(in millions, except per share amounts)

Three Months Ended June 30, 2021 2020 Six Months Ended June 30, 2021 2020
Revenues $1,177.8 $965.4 $2,118.7 $1,924.6
Operating income $133.8 $114.5 $218.5 $221.7
Operating margin percentage 11.4% 11.9% 10.3% 11.5%
Income from continuing operations $94.1 $76.0 $143.2 $140.8
Income (loss) from discontinued operations $5.2 $(0.6) $8.3 $(3.6)
Diluted earnings per share attributable to common shares:
Income from continuing operations $1.77 $1.37 $2.68 $2.52
Income (loss) from discontinued operations $0.10 $(0.01) $0.16 $(0.07)
Non-comparable items(1) $9.5 $14.2 $16.9 $27.4

(1) Non-comparable items include items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

Revenues increased in the second quarter and first six months of 2021 primarily reflecting higher volumes and price realization in our CCM and CFT segments and favorable foreign currency impacts, partially offset by lower volumes in our CIT segment, which has continued to be impacted by the prolonged aerospace decline.

The decrease in operating margin percentage in the second quarter and first six months of 2021 primarily reflected raw material and wage inflation across all segments, and unfavorable mix at CIT. The decrease in operating income was partially offset by higher volumes, price realization and savings from the Carlisle Operating System ("COS").

Diluted earnings per share from continuing operations increased primarily due to improved operating income performance ($0.26 per share in the second quarter of 2021), a lower effective tax rate ($0.13 per share in the second quarter of 2021 and $0.10 per share in the first six months of 2021), and reduced average shares outstanding ($0.07 per share in the second quarter of 2021 and $0.12 per share in the first six months of 2021) resulting from purchases under our share repurchase program. The increase was partially offset by lower operating income performance in the first six months of 2021 of $0.04.

We generated $171.5 million in operating cash flow in the first six months of 2021, and utilized cash on hand and cash provided by operations to return capital to shareholders through dividends and share repurchases, and to fund capital expenditures.

Consolidated Results of Operations

Revenues

(in millions)

2021 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Three months ended June 30 $1,177.8 $965.4 $212.4 22.0% 0.4% 20.7% 0.9%
Six months ended June 30 $2,118.7 $1,924.6 $194.1 10.1% 0.4% 8.9% 0.8%

Revenues increased in the second quarter and first six months of 2021 primarily reflecting higher sales volumes and price realization in our CCM and CFT segments across all markets in which they operate and favorable foreign currency impacts, partially offset by lower CIT volumes as a result of the prolonged aerospace decline.

Gross Margin

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Gross margin $307.7 $270.1 $37.6 13.9% $552.6 $539.5 $13.1 2.4%
Gross margin percentage 26.1% 28.0% 26.1% 28.0%
Depreciation and amortization $24.1 $26.2 $48.7 $53.0

Gross margin percentage (gross margin expressed as a percentage of revenues) declined in the second quarter and first six months of 2021, driven by raw material and wage inflation, and unfavorable mix at our CIT segment, partially offset by savings from COS. Also included in cost of goods sold were exit and disposal costs totaling $3.6 million for the second quarter and $4.4 million in the first six months of 2021, primarily at CIT, attributable to our restructuring initiatives, compared with $4.0 million for the second quarter and $5.7 million for the first six months of 2020. Refer to Note 8 for further information on exit and disposal activities.

Selling and Administrative Expenses

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Selling and administrative expenses $161.3 $144.6 $16.7 11.5% $312.1 $295.5 $16.6 5.6%
As a percentage of revenues 13.7% 15.0% 14.7% 15.4%
Depreciation and amortization $25.0 $24.3 $49.2 $47.9

The increase in selling and administrative expenses in the second quarter and first six months of 2021 primarily reflected higher medical costs, higher incentive compensation costs and wage inflation. Also included in selling and administrative expenses were exit and disposal costs totaling $2.8 million for the second quarter and $3.4 million for the first six months of 2021, primarily at CIT, attributable to our restructuring initiatives, compared with $2.7 million for the second quarter and $2.8 million for the first six months of 2020. Refer to Note 8 for further information on exit and disposal activities.

Research and Development Expenses

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Research and development expenses $13.8 $11.7 $2.1 17.9% $24.2 $23.6 $0.6 2.5%
As a percentage of revenues 1.2% 1.2% 1.1% 1.2%
Depreciation and amortization $0.4 $0.5 $0.9 $1.0

Research and development expenses were higher in the second quarter and first six months of 2021, compared with the 2020 periods, primarily reflecting higher new product development expenses at our CIT segment.

Other Operating Income, net

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Other operating income, net $(1.2) $(0.7) $(0.5) 71.4% $(2.2) $(1.3) $(0.9) 69.2%

Other operating income, net in the 2021 periods primarily reflected rebates ($0.8 million in second-quarter and $1.7 million in the first six months) and royalty income ($0.4 million in second-quarter and $0.7 million in the first six months), partially offset by an insurance settlement of $0.5 million in both the second-quarter and first six months at CCM.

Other operating income, net in the 2020 periods primarily reflected rebates ($0.7 million in second-quarter and $1.2 million in the first six months) and royalty income ($0.3 million in second-quarter and $0.7 million in the first six months), partially offset by losses on sale of assets ($0.8 in second-quarter and $1.5 million in the first six months), primarily at CIT and CCM.

Operating Income

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Operating income $133.8 $114.5 $19.3 16.9% $218.5 $221.7 $(3.2) (1.4)%
Operating margin percentage 11.4% 11.9% 10.3% 11.5%

Refer to Segment Results of Operations within this MD&A for further information related to segment operating income results.

Interest Expense, net

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Interest expense, net $19.2 $19.7 $(0.5) (2.5)% $38.4 $38.7 $(0.3) (0.8)%

Interest expense, net of capitalized interest, declined in the second quarter and first six months of 2021 primarily reflecting draws on our revolving credit facility in the first quarter of 2020, which were repaid in the second quarter of 2020. Refer to Note 12 for further information on our long-term debt.

Loss on Extinguishment of Debt

Loss on extinguishment of debt of $8.8 million in the first six months of 2020 related to the early redemption in full of our $250.0 million aggregate principal amount of our outstanding 5.125% notes due December 15, 2020 (the “2020 Notes”). The 2020 Notes were redeemed on March 29, 2020 at the redemption price of $262.1 million. The redemption price included a premium of $8.4 million, along with $0.4 million of deferred issuance costs.

Interest Income

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Interest income $(0.4) $(2.6) $2.2 (84.6)% $(0.9) $(3.3) $2.4 (72.7)%

Interest income decreased during the second quarter and first six months of 2021 primarily reflecting lower cash balances and lower yields.

Other Non-operating Expense (Income), net

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Other non-operating expense (income), net $1.1 $(0.7) $1.8 NM $4.7 $(0.9) $5.6 NM

Other non-operating expense (income), net in the first six months of 2021 primarily reflected the release of a portion of the indemnification asset related to the Petersen Aluminum Corporation ("Petersen") acquisition resulting from escrow expirations and changes in foreign currencies against the U.S. Dollar.

Other non-operating expense (income), net, in the first six months of 2020 primarily reflected foreign exchange gains from the strengthening of the U.S. Dollar, partially offset by the release of a portion of the indemnification asset related to the Petersen acquisition resulting from escrow expirations.

Income Taxes

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Provision for income taxes $19.8 $22.1 $(2.3) (10.4)% $33.1 $37.6 $(4.5) (12.0)%
Effective tax rate 17.4% 22.5% 18.8% 21.1%

The effective income tax rate on continuing operations for the first six months of 2021 was 18.8%. The year-to-date provision for income taxes included taxes on earnings at an anticipated rate of 24.4% and a tax impact of $9.8 million related to discrete activity. The year-to-date net discrete tax benefit relates primarily to a reduction of prior year tax liabilities and excess tax benefits related to stock compensation.

The effective income tax rate on continuing operations for the first six months of 2020 was 21.1%.

Income (Loss) from Discontinued Operations

(in millions)

2021 Three Months Ended June 30, 2020 Change% 2021 Six Months Ended June 30, 2020 Change%
Income (loss) from discontinued operations before taxes $6.3 $(1.1) $7.4 (672.7)% $10.8 $(5.2) $16.0 (307.7)%
Provision for (benefit from) income taxes 1.1 (0.5) 2.5 (1.6)
Income (loss) from discontinued operations $5.2 $(0.6) $8.3 $(3.6)

Income (loss) from discontinued operations for the second quarter and first six months of 2021 reflects improved operating results from the CBF segment, compared with the 2020 periods, partially offset by pre-close transaction costs incurred in the second quarter of 2021.

Segment Results of Operations

Carlisle Construction Materials ("CCM")

CCM continues to benefit from the strong re-roofing cycle in the United States. All of CCM's platforms delivered double digit sales growth, while our architectural metals and spray foam insulation product lines delivered over 40% growth. CCM is committed to delivering the full value of the Carlisle Experience and being the manufacturer of choice with second-to-none reliability for all of our channel partners. These efforts were clearly demonstrated in the second quarter with solid execution meeting unusually strong demand despite the significant supply constraints. CCM continues to operate with agility and precision, adjusting quickly to the downturn in 2020, and just as quickly adjusting to the upturn in 2021.

On June 2, 2021, we announced that construction has begun on CCM's sixth thermoplastic polyolefin ("TPO") manufacturing line, which will produce the commercial roofing industry's first 16-foot-wide TPO membranes. Located in Carlisle, Pennsylvania, the new line will add to CCM's industry-leading production capacity with the widest TPO sheets on the market. Consistent with Carlisle's Vision 2025 strategy to invest in high-returning businesses, the new TPO line will support organic growth initiatives and also create jobs for the city of Carlisle and surrounding communities. The new line is expected to begin production in early 2022.

On April 20, 2021, Carlisle announced plans to build an innovative, state-of-the-art polyiso insulation manufacturing facility in Sikeston, Missouri. Consistent with Carlisle’s Vision 2025 strategy to invest in high-returning businesses to drive organic growth, the plant will support organic growth initiatives and create new jobs for the city of Sikeston and surrounding communities. The building will be constructed in accordance with the latest advances in LEED building and ESG principles. Additionally, we expect that this central location will reduce our supply chain carbon footprint and improve material lead times for customers in this region where the use of insulation in the building envelope is steadily increasing. At the new facility, CCM will manufacture energy-efficient polyiso insulation, which not only lowers energy costs for building owners and operators, but also helps reduce a building's greenhouse gas emissions.

Our new investments in Sikeston, Missouri and industry-first 16 foot-wide TPO line in Carlisle, Pennsylvania are evidence of our conviction in CCM's attractive long-term growth prospects.

(in millions)

2021 Three Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $937.3 $734.9 $202.4 27.5% —% 26.8% 0.7%
Operating income $177.4 $137.6 $39.8 28.9%
Operating margin percentage 18.9% 18.7%
Depreciation and amortization $23.5 $25.0
Non-comparable items(1) $0.4 $2.2

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the second quarter of 2021 primarily reflecting higher volumes from strength in U.S. commercial roofing demand and price realization.

CCM’s operating margin percentage increase in the second quarter of 2021 primarily reflected higher volumes, price realization and savings from COS, partially offset by raw material and wage inflation.

(in millions)

2021 Six Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $1,656.6 $1,411.3 $245.3 17.4% —% 16.7% 0.7%
Operating income $298.7 $245.3 $53.4 21.8%
Operating margin percentage 18.0% 17.4%
Depreciation and amortization $46.9 $49.8
Non-comparable items (1) $2.7 $2.8

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CCM’s revenue increased in the first six months of 2021 primarily reflecting higher volumes from strength in U.S. commercial roofing demand and price realization.

CCM’s operating margin percentage increase in the first six months of 2021 primarily reflected higher volumes, price realization and savings from COS, partially offset by raw material and wage inflation.

Carlisle Interconnect Technologies ("CIT")

CIT's results were in line with subdued expectations. Given expanding global vaccine rollout, increased domestic travel, European countries opening their borders to American and other vaccinated travelers and improvements in CIT's order book, we continue to believe CIT is positioned for sequential improvement going forward. Taken together with the improving backlog in our medical technologies product lines, we are optimistic CIT will return to growth in the second half of 2021.

In 2020, as a result of the market declines caused by the effects of the COVID-19 pandemic, we announced the closure of our manufacturing operations in Kent, Washington, and the relocation of selected operations to our existing facilities primarily in North America. This project is estimated to take a remaining 4 to 8 months to complete. Total project costs are expected to approximate $17.7 million, with approximately $3.5 million remaining to be incurred.

(in millions)

2021 Three Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $168.9 $184.0 $(15.1) (8.2)% 1.1% (9.7)% 0.4%
Operating loss $(12.9) $(1.5) $(11.4) (760.0)%
Operating margin percentage (7.6)% (0.8)%
Depreciation and amortization $18.7 $19.7
Non-comparable items(1) $7.7 $5.0

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenue decline in the second quarter of 2021 primarily reflected lower volumes, led by the downturn in the commercial aerospace market as a result of slow recovery in build rates on narrow and wide body aircraft by original equipment manufacturers ("OEMs") given declines in airline travel.

CIT’s operating margin percentage decrease in the second quarter of 2021 was driven by lower volumes, unfavorable mix, and raw material and wage inflation, partially offset by savings from COS and lower travel and other administrative costs.

(in millions)

2021 Six Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $324.7 $408.5 $(83.8) (20.5)% 0.9% (21.7)% 0.3%
Operating (loss) income $(23.6) $14.9 $(38.5) (258.4)%
Operating margin percentage (7.3)% 3.6%
Depreciation and amortization $37.6 $38.8
Non-comparable items(1) $10.5 $8.4

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CIT's revenue decline in the first six months of 2021 primarily reflected lower volumes, led by the downturn in the commercial aerospace market as a result of slow recovery in build rates on narrow and wide body aircraft by OEMs given declines in airline travel.

CIT’s operating margin percentage decreased in the first six months of 2021, driven by lower volumes, unfavorable mix, and raw material and wage inflation, partially offset by savings from COS and lower travel and other administrative costs.

Carlisle Fluid Technologies ("CFT")

CFT delivered improved revenue and operating income performance in the quarter driven by a commitment to new product introductions, price discipline and integrating our newer platforms. With end markets strengthening, the team continues to execute on Vision 2025 initiatives and focus on enhancing our customers' experience.

(in millions)

2021 Three Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $71.6 $46.5 $25.1 54.0% 3.6% 44.3% 6.1%
Operating income (loss) $6.6 $(5.2) $11.8 226.9%
Operating margin percentage 9.2% (11.2)%
Depreciation and amortization $5.9 $5.4
Non-comparable items(1) $— $2.1

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the second quarter of 2021 reflecting increased volumes, particularly in the transportation end market, price realization, favorable foreign currency impacts and contributions from acquisitions.

CFT’s operating margin percentage performance improved in the second quarter of 2021 reflecting higher volumes, price realization and savings from COS, partially offset by wage and raw material inflation.

(in millions)

2021 Six Months Ended June 30, 2020 Change% Acquisition Effect Price / Volume Effect Exchange Rate Effect
Revenues $137.4 $104.8 $32.6 31.1% 3.9% 22.7% 4.5%
Operating income (loss) $10.9 $(2.4) $13.3 554.2%
Operating margin percentage 7.9% (2.3)%
Depreciation and amortization $11.5 $11.6
Non-comparable items(1) $0.7 $2.3

(1) Non-comparable items include items that, by their nature, tend to obscure the segment’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. Refer to Non-GAAP Financial Measures in this MD&A for a detailed reconciliation of these items.

CFT's revenue increased in the first six months of 2021 reflecting increased volumes, particularly in the transportation end market, price realization, favorable foreign currency impacts and contributions from acquisitions.

CFT’s operating margin percentage performance improved for the first six months of 2021, reflecting higher volumes, price realization and savings from COS, partially offset by wage and raw material inflation.

Liquidity and Capital Resources

A summary of our cash and cash equivalents by region follows:

(in millions)

June 30, 2021 December 31, 2020
Europe $135.6 $113.7
North America (excluding U.S.) 49.3 50.8
China 6.3 18.4
Asia Pacific (excluding China) 34.5 27.0
International cash and cash equivalents 225.7 209.9
U.S. cash and cash equivalents 487.6 687.2
Total cash and cash equivalents $713.3 $897.1

We maintain liquidity sources primarily consisting of cash and cash equivalents as well as availability under our Facility. In the near term, cash on hand is our primary source of liquidity. The decrease in cash and cash equivalents compared to December 31, 2020, primarily related to share repurchases, payment of dividends to shareholders and capital expenditures.

In certain countries, primarily China, our cash is subject to local laws and regulations that require government approval for conversion of such cash to U.S. Dollars, as well as for transfer of such cash, both temporarily and permanently outside of that jurisdiction. In addition, upon permanent transfer of cash outside of certain jurisdictions, primarily in China, we may be subject to withholding taxes, and as such we have accrued $3.3 million in anticipation of those taxes as of June 30, 2021.

We believe we have sufficient cash on hand, availability under the Facility and operating cash flows to meet our business requirements for at least the next 12 months. At the discretion of management, the Company may use available cash on capital expenditures, dividends, common stock repurchases, acquisitions and strategic investments.

We also anticipate we will have sufficient cash on hand, as well as available liquidity under the Facility, to pay outstanding principal balances of our existing notes by the respective maturity dates. Another potential source of liquidity is access to public capital markets, subject to market conditions. We may access the capital markets to repay the outstanding balance. Refer to Debt Instruments below.

Sources and Uses of Cash and Cash Equivalents

(in millions)

Six Months Ended June 30, 2021 2020
Net cash provided by operating activities $171.5 $226.3
Net cash used in investing activities (63.5) (50.0)
Net cash (used in) provided by financing activities (284.5) 214.7
Effect of foreign currency exchange rate changes on cash (0.3) (4.5)
Change in cash and cash equivalents $(176.8) $386.5

Operating Activities

We generated operating cash flows of $171.5 million for the first six months of 2021 (including working capital uses of $103.9 million), compared with $226.3 million for the first six months of 2020 (including working capital uses of $69.0 million). Lower operating cash flows in the first six months of 2021 primarily reflected an increase in receivables from higher sales, partially offset by higher payables due to rising raw material costs.

Investing Activities

Cash used in investing activities of $63.5 million for the first six months of 2021 primarily reflected capital expenditures of $55.1 million and investment in securities of $10.2 million. Cash used in investing activities of $50.0 million for the first six months of 2020 primarily reflected capital expenditures of $48.5 million.

Financing Activities

Cash used in financing activities of $284.5 million in the first six months of 2021 primarily reflected share repurchases of $265.6 million and cash dividend payments of $56.0 million, reflecting the increased quarterly dividend of $0.525 per share. Cash provided by financing activities of $214.7 million during the first six months of 2020 primarily reflected net proceeds from our February 2020 offering of $750 million of senior notes and draws under the Facility, partially offset by the early redemption of our $250 million of senior notes due December 15, 2020 and financing costs associated with our February notes offering. Additionally during the first six months of 2020 we used cash of $191.8 million for share repurchases and $56.0 million for dividend payments.

Debt Instruments

Revolving Credit Facility (the "Facility")

During the first six months of 2021, we had no borrowings or repayments under the Facility. As of June 30, 2021, the Facility had no outstanding balance and $1.0 billion of availability. During the first six months of 2020, borrowings and repayments under the Facility totaled $500.0 million.

Debt Covenants

We are required to meet various covenants and limitations under our senior notes and Facility, including certain leverage ratios, interest coverage ratios and limits on outstanding debt balances held by certain subsidiaries. We were in compliance with all covenants and limitations as of June 30, 2021 and December 31, 2020.

Refer to Note 12 for further information on our debt instruments.

Non-GAAP Financial Measures

EBIT, Adjusted EBIT, Adjusted EBITDA and Adjusted EBITDA Margin

Earnings before interest and taxes ("EBIT"), adjusted EBIT, adjusted earnings before income, taxes, depreciation and amortization ("EBITDA") and adjusted EBITDA margin are intended to provide investors and others with information about the Company's and its segments' performance without the effect of items that, by their nature, tend to obscure core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies. This information differs from net income and operating income determined in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and should not be considered in isolation or as a substitute for measures of performance determined in accordance with U.S. GAAP. The Company's and its segments' EBIT, adjusted EBIT, adjusted EBITDA and adjusted EBITDA margin follows. These non-GAAP financial measures may not be comparable to similarly titled measures reported by other companies.

(in millions)

Three Months Ended June 30, 2021 2020 Six Months Ended June 30, 2021 2020
Net income (GAAP) $99.3 $75.4 $151.5 $137.2
Less: income (loss) from discontinued operations (GAAP) 5.2 (0.6) 8.3 (3.6)
Income from continuing operations (GAAP) 94.1 76.0 143.2 140.8
Provision for income taxes 19.8 22.1 33.1 37.6
Interest expense, net 19.2 19.7 38.4 38.7
Interest income (0.4) (2.6) (0.9) (3.3)
EBIT 132.7 115.2 213.8 213.8
Exit and disposal, and facility rationalization costs 7.5 7.3 10.6 10.8
Inventory step-up amortization and acquisition costs 1.3 4.9 2.2 5.6
Impairment charges — — — —
Losses from acquisitions and disposals 0.1 2.0 3.5 2.2
Losses from insurance 0.5 — 0.5 —
Losses from litigation 0.1 — 0.1 —
Losses on extinguishment of debt — — — 8.8
Total non-comparable items 9.5 14.2 16.9 27.4
Adjusted EBIT 142.2 129.4 230.7 241.2
Depreciation 20.3 21.2 40.6 41.4
Amortization 29.2 29.8 58.2 60.5
Adjusted EBITDA $191.7 $180.4 $329.5 $343.1
Divided by:
Total revenues $1,177.8 $965.4 $2,118.7 $1,924.6
Adjusted EBITDA margin 16.3% 18.7% 15.6% 17.8%

31

(in millions)

Three Months Ended June 30, 2021 CCM CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $177.4 $(12.9) $6.6 $(37.3)
Non-operating expense (income)(1) 0.1 — 1.1 (0.1)
EBIT 177.3 (12.9) 5.5 (37.2)
Exit and disposal, and facility rationalization costs — 7.7 (0.2) —
Inventory step-up amortization and acquisition costs — — — 1.3
Impairment charges — — — —
(Gains) losses from acquisitions and disposals (0.1) — 0.2 —
Losses from insurance 0.5 — — —
Losses from litigation — — — 0.1
Losses on extinguishment of debt — — — —
Total non-comparable items 0.4 7.7 — 1.4
Adjusted EBIT 177.7 (5.2) 5.5 (35.8)
Depreciation 12.0 6.0 1.4 0.9
Amortization 11.5 12.7 4.5 0.5
Adjusted EBITDA $201.2 $13.5 $11.4 $(34.4)
Divided by:
Total revenues $937.3 $168.9 $71.6 $—
Adjusted EBITDA margin 21.5% 8.0% 15.9% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

(in millions)

Three Months Ended June 30, 2020 CCM CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $137.6 $(1.5) $(5.2) $(16.4)
Non-operating expense (income)(1) 2.6 0.2 — (3.5)
EBIT 135.0 (1.7) (5.2) (12.9)
Exit and disposal, and facility rationalization costs 0.2 5.0 2.1 —
Inventory step-up amortization and acquisition costs — — — 4.9
Impairment charges — — — —
Losses (gains) from acquisitions and disposals 2.0 — — —
Losses (gains) from insurance — — — —
Losses (gains) from litigation — — — —
Losses on extinguishment of debt — — — —
Total non-comparable items 2.2 5.0 2.1 4.9
Adjusted EBIT 137.2 3.3 (3.1) (8.0)
Depreciation 12.5 6.6 1.3 0.8
Amortization 12.5 13.1 4.1 0.1
Adjusted EBITDA $162.2 $23.0 $2.3 $(7.1)
Divided by:
Total revenues $734.9 $184.0 $46.5 $—
Adjusted EBITDA margin 22.1% 12.5% 4.9% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

(in millions)

Six Months Ended June 30, 2021 CCM CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $298.7 $(23.6) $10.9 $(67.5)
Non-operating expense(1) 2.3 — 1.5 0.9
EBIT 296.4 (23.6) 9.4 (68.4)
Exit and disposal, and facility rationalization costs — 10.2 0.4 —
Inventory step-up amortization and acquisition costs — — 0.1 2.1
Impairment charges — — — —
Losses from acquisitions and disposals 2.2 0.3 0.2 0.8
Losses from insurance 0.5 — — —
Losses from litigation — — — 0.1
Losses on extinguishment of debt — — — —
Total non-comparable items 2.7 10.5 0.7 3.0
Adjusted EBIT 299.1 (13.1) 10.1 (65.4)
Depreciation 23.9 12.3 2.6 1.8
Amortization 23.0 25.3 8.9 1.0
Adjusted EBITDA $346.0 $24.5 $21.6 $(62.6)
Divided by:
Total revenues $1,656.6 $324.7 $137.4 $—
Adjusted EBITDA margin 20.9% 7.5% 15.7% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

(in millions)

Six Months Ended June 30, 2020 CCM CIT CFT Corporate and unallocated
Operating income (loss) (GAAP) $245.3 $14.9 $(2.4) $(36.1)
Non-operating expense income)(1) 2.9 (0.6) (3.3) 8.9
EBIT 242.4 15.5 0.9 (45.0)
Exit and disposal, and facility rationalization costs 0.3 8.4 2.1 —
Inventory step-up amortization and acquisition costs 0.2 — 0.2 5.2
Impairment charges — — — —
Losses (gains) from acquisitions and disposals 2.3 — — (0.1)
Losses from insurance — — — —
Losses from litigation — — — —
Losses on extinguishment of debt — — — 8.8
Total non-comparable items 2.8 8.4 2.3 13.9
Adjusted EBIT 245.2 23.9 3.2 (31.1)
Depreciation 24.7 12.6 2.6 1.5
Amortization 25.1 26.2 9.0 0.2
Adjusted EBITDA $295.0 $62.7 $14.8 $(29.4)
Divided by:
Total revenues $1,411.3 $408.5 $104.8 $—
Adjusted EBITDA margin 20.9% 15.3% 14.1% NM

(1) Includes other non-operating (income) expense, which may be presented in separate line items on the Condensed Consolidated Statements of Income.

Outlook

Our expectations for segment and total revenues for 2021, compared to 2020 follow:

2021 Revenue Primary Drivers
Carlisle Construction Materials High-teens growth •Strong re-roofing demand •Price discipline •Strong architectural metals, European and polyurethane markets
Carlisle Interconnect Technologies Mid-to-high-single digit decline •Commercial aerospace performance at or near bottom; backlog improving
Carlisle Fluid Technologies Mid-teens growth •Focus on new product introductions and price realization •Markets strengthening
Total Carlisle Mid-teens growth

For the year 2021, we expect:

  • Corporate expenses of approximately $125 million;
  • Depreciation and amortization expense of approximately $210 million;
  • Capital expenditures of approximately $150 million;
  • Interest expense, net of interest income, of approximately $75 million; and
  • Base tax rate of approximately 25%.

Forward-Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the potential or expected impacts of the global COVID-19 pandemic. Forward-looking statements generally use words such as "expect," "foresee," "anticipate," "believe," "project," "should," "estimate," "will," "plans," "intends," "forecast," and similar expressions, and reflect our expectations concerning the future. Such statements are made based on known events and circumstances at the time of publication and, as such, are subject in the future to unforeseen risks and uncertainties. It is possible that our future performance may differ materially from current expectations expressed in these forward-looking statements, due to a variety of factors such as: risks from the global COVID-19 pandemic, including, for example, expectations regarding the impact of COVID-19 on our businesses, including on customer demand, supply chains and distribution systems, production, our ability to maintain appropriate labor levels, our ability to ship products to our customers, our future results, or our full-year financial outlook; increasing price and product/service competition by foreign and domestic competitors, including new entrants; technological developments and changes; the ability to continue to introduce competitive new products and services on a timely, cost-effective basis; our mix of products/services; increases in raw material costs which cannot be recovered in product pricing; domestic and foreign governmental and public policy changes including environmental and industry regulations; threats associated with and efforts to combat terrorism; protection and validity of patent and other intellectual property rights; the identification of strategic acquisition targets and our successful completion of any transaction and integration of our strategic acquisitions, including Henry; our successful completion of strategic dispositions, including CBF; the cyclical nature of our businesses; and the outcome of pending and future litigation and governmental proceedings; and the other factors discussed in the reports we file with or furnish to the Securities and Exchange Commission ("SEC") from time to time. In addition, such statements could be affected by general industry and market conditions and growth rates, the condition of the financial and credit markets and general domestic and international economic conditions including interest rate and currency exchange rate fluctuations. Further, any conflict in the international arena may adversely affect general market conditions and our future performance. Any forward-looking statement speaks only as of the date on which that statement is made, and we undertake no duty to update any forward-looking statement to reflect events or circumstances, including unanticipated events, after the date on which that statement is made, unless otherwise required by law. New factors emerge from time to time and it is not possible for management to predict all of those factors, nor can it assess the impact of each of those factors on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.

Market risk

As filed, 269 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company’s market risk for the six months ended June 30, 2021. For additional information, refer to "PART II—Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the Company’s 2020 Annual Report on Form 10-K.

Controls and procedures

As filed, 858 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of disclosure controls and procedures. Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-15. Based upon that evaluation and as of June 30, 2021, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective.

b. Changes in internal controls. During the first six months of 2021, there were no changes in the Company's internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Risk factors

As filed, 149 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes in the Company's risk factors disclosed in "PART I—Item 1A. Risk Factors" in our 2020 Annual Report on Form 10-K.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-04-01 to 2021-06-30$1.18bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2021-01-01 to 2021-06-30$2.12bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-04-01 to 2021-06-30$870.1mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2021-01-01 to 2021-06-30$1.57bnus-gaap:CostOfGoodsAndServicesSold
Research and development3 months2021-04-01 to 2021-06-30$13.8mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$24.2mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-04-01 to 2021-06-30$161.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2021-01-01 to 2021-06-30$312.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-04-01 to 2021-06-30$133.8mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30$218.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-04-01 to 2021-06-30$19.2mus-gaap:InterestExpense
Interest expense6 months2021-01-01 to 2021-06-30$38.4mus-gaap:InterestExpense
Income tax3 months2021-04-01 to 2021-06-30$19.8mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2021-01-01 to 2021-06-30$33.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-04-01 to 2021-06-30$99.3mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30$151.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30$1.87us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30$2.84us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-04-01 to 2021-06-30$1.89us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-01-01 to 2021-06-30$2.87us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-04-01 to 2021-06-3053,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-01-01 to 2021-06-3053,300,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30$171.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$55.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2021-01-01 to 2021-06-30$56.0mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2021-01-01 to 2021-06-30$265.6mus-gaap:PaymentsForRepurchaseOfCommonStock
Current assetsAt period end2021-06-30$2.51bnus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$5.84bnus-gaap:Assets
Current liabilitiesAt period end2021-06-30$761.7mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2021-06-30$2.08bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-06-30$1.2mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-06-30$2.42bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000790051-21-000175. Last ingested by Listed: Nov 10, 2026, 16:42 ET. Listed shows no prices and gives no investment advice.